PRAX
PRAX
NASDAQ · Biotechnology

Praxis Precision Medicines I

$330.02
-3.26 (-0.98%)
As of May 10, 9:46 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 19 86%
Hold 2 9%
Sell 1 5%
Price Target
Analyst Price Target -94.1% upside
Low Target $15.93
Average Target $19.45
High Target $25.00
Current Price $330.02
Current
$330.02
Target
$19.45
$15.93 $19.45 avg $25.00
Scenario Analysis
Bear Case
$15.93
-95.2%
Low target
Base Case
$19.45
-94.1%
Avg target
Bull Case
$25.00
+-92.4%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$356.00
-7.3% from high
52-Week Low
$35.18
+838.1% from low
50-Day SMA
$296.27
+11.4% vs SMA
200-Day SMA
$133.67
+146.9% vs SMA
RSI (14)
61.8
Neutral
Target vs 52W High
$19.45
-94.5% vs high
Next Earnings Report
May 13, 2026
1d
tomorrow
EPS Est: $-3.64
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%